These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11569404)

  • 21. Autoreactivity of T cells from nonobese diabetic mice: an I-Ag7-dependent reaction.
    Kanagawa O; Martin SM; Vaupel BA; Carrasco-Marin E; Unanue ER
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1721-4. PubMed ID: 9465083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limited heterogeneity of autoantigens and T cells in autoimmune diseases?
    Acha-Orbea H
    Res Immunol; 1991; 142(5-6):487-90. PubMed ID: 1754724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent.
    Serreze DV; Chapman HD; Varnum DS; Gerling I; Leiter EH; Shultz LD
    J Immunol; 1997 Apr; 158(8):3978-86. PubMed ID: 9103469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spontaneous T-cell proliferation in the non-obese diabetic mouse to a peptide from the unique class II MHC molecule, I-Ag7, which is also protective against the development of autoimmune diabetes.
    Xu XJ; Gearon C; Stevens E; Vergani D; Baum H; Peakman M
    Diabetologia; 1999 May; 42(5):560-5. PubMed ID: 10333048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [1990 Apollinaire Bouchardat Prize. Immunology of insulin-dependent diabetes mellitus: in vitro and in vivo study models in animals].
    Boitard C
    Journ Annu Diabetol Hotel Dieu; 1990; ():285-99. PubMed ID: 2195212
    [No Abstract]   [Full Text] [Related]  

  • 26. H-2D end confers dominant protection from IL-10-mediated acceleration of autoimmune diabetes in the nonobese diabetic mouse.
    La Cava A; Balasa B; Good A; van Gunst K; Jung N; Sarvetnick N
    J Immunol; 2001 Jul; 167(2):1066-71. PubMed ID: 11441117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The murine autoimmune diabetes model: NOD and related strains.
    Kikutani H; Makino S
    Adv Immunol; 1992; 51():285-322. PubMed ID: 1323922
    [No Abstract]   [Full Text] [Related]  

  • 28. Enhanced expression of CD44 isoforms in nonobese diabetic (NOD) mice.
    Milde KF; Alejandro R; Pastori RL
    Transplant Proc; 1995 Dec; 27(6):3409. PubMed ID: 8540022
    [No Abstract]   [Full Text] [Related]  

  • 29. Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model.
    Toyoda H; Formby B
    Bioessays; 1998 Sep; 20(9):750-7. PubMed ID: 9819564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of major histocompatibility complex class II antigen in NOD mouse thyroid.
    Margolese H; O'Keefe C; Chung F; Ertug F; Wall JR; Bernard NF
    Autoimmunity; 1994; 17(1):1-11. PubMed ID: 8025210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Non Obese Diabetic (NOD) mouse, as a model of T cell mediated autoimmune disease.
    Bach JF
    C R Acad Sci III; 1992; 314(9 Suppl):45-6. PubMed ID: 1422905
    [No Abstract]   [Full Text] [Related]  

  • 32. A self MHC class II beta-chain peptide prevents diabetes in nonobese diabetic mice.
    Chaturvedi P; Agrawal B; Zechel M; Lee-Chan E; Singh B
    J Immunol; 2000 Jun; 164(12):6610-20. PubMed ID: 10843721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell autoimmunity in type 1 diabetes mellitus.
    Birk OS; Cohen IR
    Curr Opin Immunol; 1993 Dec; 5(6):903-9. PubMed ID: 8297523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune diabetes-prone NOD mice express the Lyt2 alpha (Lyt2.1) and Lyt3 alpha (Lyt3.1) alleles of CD8.
    Johnson-Tardieu JM; Walworth EW; Cornelius JG; Ye X; Schuster SM; Peck AB
    Immunogenetics; 1996; 43(1-2):6-12. PubMed ID: 8537123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmunity and HLA.
    Carpenter CB
    J Clin Immunol; 1982 Jul; 2(3):157-65. PubMed ID: 6811606
    [No Abstract]   [Full Text] [Related]  

  • 36. Reduction in diabetes incidence in an I-Ag7 transgenic nonobese diabetic mouse line.
    Wherrett DK; Singer SM; McDevitt HO
    Diabetes; 1997 Dec; 46(12):1970-4. PubMed ID: 9392482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibodies: probes for studying experimental autoimmunity in animals.
    Boitard C; Sempé P; Villà MC; Becourt C; Richard MF; Timsit J; Bach JF
    Res Immunol; 1991; 142(5-6):495-503. PubMed ID: 1754725
    [No Abstract]   [Full Text] [Related]  

  • 38. Autoimmune diabetes mellitus--much progress, but many challenges.
    McDevitt HO; Unanue ER
    Adv Immunol; 2008; 100():1-12. PubMed ID: 19111161
    [No Abstract]   [Full Text] [Related]  

  • 39. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice.
    Serreze DV; Gaskins HR; Leiter EH
    J Immunol; 1993 Mar; 150(6):2534-43. PubMed ID: 8450229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A minor subset of Batf3-dependent antigen-presenting cells in islets of Langerhans is essential for the development of autoimmune diabetes.
    Ferris ST; Carrero JA; Mohan JF; Calderon B; Murphy KM; Unanue ER
    Immunity; 2014 Oct; 41(4):657-69. PubMed ID: 25367577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.